乌鸦传媒

<乌鸦传媒 class="page-title">Clinical Challenges

ASH: AML

<乌鸦传媒 class="page-description">American Society of Hematology

More in ASH: AML

Clinical Challenges: Targeting Menin in Acute Myeloid Leukemia

Early trials of novel inhibitors show promise in selected patients

Jan 04, 2023
ASH over a photo of Ernest N. Morial Convention Center in New Orleans, Louisiana.
Clinical Challenges: Treating AML With IDH1 and IDH2 Mutations

Development of IDH inhibitors has changed the treatment landscape

Dec 27, 2022
ASH over a photo of Ernest N. Morial Convention Center in New Orleans, Louisiana.
Clinical Challenges: Treating AML in Older and Unfit Patients

Lower-intensity therapies now available and effective for these patients

Dec 19, 2022
ASH over a photo of Ernest N. Morial Convention Center in New Orleans, Louisiana.
Clinical Challenges: Specialist Palliative Care in Acute Myeloid Leukemia

Advocates say patients would benefit greatly from more referrals

Dec 22, 2021
ASH over a photo of the Georgia World Conference Center in Atlanta, GA.

1.00 CME Credits
Improving Transitions of Care and Long-Term Outcomes for Patients With Spinal Muscular Atrophy (SMA)

3.00 CME Credits
Pain Management and the 2022 CDC Guideline for Prescribing Opioids for Pain

1.00 CME Credits
Engaging Older Adults in Vaccine Education: A Toolkit for Healthcare Providers

1.00 CME Credits
Uncomplicated Urinary Tract Infections: Leveraging Real-World Insights to Improve Patient Care

0.25 CME Credits
Utilizing Biomarkers and Prognostic Factors to Identify Rheumatoid Arthritis Patients at Risk for Poor Outcomes

0.50 CME Credits
Enhancing Vaccine Uptake in Older Adults: Supporting Conversations With Your Patients

0.50 CME Credits
The Latest Evidence for Integrating Biomarkers and Prognostic Factors Into Treatment Plans for Patients With Rheumatoid Arthritis

0.25 CME Credits
Leveraging the Latest Data to Guide Precision Medicine in Rheumatoid Arthritis